Vifor : Kapruvia Receives Positive CHMP Opinion For Treatment Of Moderate-to-severe Pruritus
28/2 07:29
(RTTNews) - Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics Inc. (CARA) said that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended approval of Kapruvia (difelikefalin) for the treatment of moderate-to-severe pr...